MedDataX Logo

Evaluation of e-Practice Self-Regulation (e-PS-R)

NCT03242447 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 631

Last updated 2022-12-09

No results posted yet for this study

Summary

The purpose of the study is to determine the impact of the offer to participate in the e-Practice Self-Regulation (e-PS-R) (treatment) relative to the control condition on increasing knowledge of sexual health and the impact of trauma on sexual decision-making and preventing teen pregnancy and high-risk behaviors 12 months after enrollment.

Conditions

  • Teen Pregnancy Prevention

Interventions

BEHAVIORAL

e-Practice Self-Regulation

e-PS-R utilizes 'blended learning', the combination of online and face-to-face instruction, and incorporates online videos and interactive elements that have been shown to be effective with high-risk youth. e-PS-R consists of eight 30-minute e-learning sessions for youth participants and four 30-45 minute one-on-one in-person meetings between youth and a trained facilitator.

BEHAVIORAL

Video Health Group

The video for the control condition will be The Toxic Life Cycle of a Cigarette, a 17-minute video that details the negative effects that cigarettes have on the environment and on people who manufacture and use cigarettes.

Sponsors & Collaborators

  • Department of Health and Human Services

    collaborator FED

  • The Policy & Research Group

    lead OTHER

Principal Investigators

  • Eric Jenner, PhD · The Policy & Research Group

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
14 Years
Max Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-02
Primary Completion
2020-04-30
Completion
2021-01-31

Countries

  • United States

Study Locations

Related Clinical Trials

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03242447 on ClinicalTrials.gov